Biomarin Pharmaceutical Inc. (BMRN)

Index:

Nasdaq 100

$ 57.36
   
  • Change Today:
    $0.31
  • 52 Week High: $93.84
  • 52 Week Low: $56.08
  • Currency: US Dollars
  • Shares Issued: 179.84m
  • Volume: 1,401,419
  • Market Cap: $10,316m
  • RiskGrade: 181

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16 31-Dec-15
Continuing Operations          
Revenue 1,704.05 1,491.21 1,313.65 1,116.85 889.90
Operating Profit/(Loss) (100.46) (123.52) (14.70) (803.43) (110.70)
Profit Before Tax (94.81) (142.71) (35.88) (831.05) (154.72)
Profit After Tax (23.85) (77.21) (117.04) (630.21) (171.80)
           
Earnings per Share - Basic (13.00¢) (44.00¢) (67.00¢) (380.00¢) (107.00¢)
Earnings per Share - Adjusted (13.00¢) (44.00¢) (67.00¢) (380.00¢) (107.00¢)
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16 31-Dec-15
Assets          
Non-Current Assets          
Property, Plant & Equipment 1,010.87 948.68 896.70 798.77 704.21
Intangible Assets 653.62 688.85 714.55 750.82 881.03
Other Non-Current Assets 1,083.41 733.38 814.73 1,052.31 1,054.49
  2,747.90 2,370.91 2,425.98 2,601.90 2,639.73
Current Assets          
Inventories 680.27 530.87 475.77 355.13 271.68
Cash at Bank & in Hand 437.45 493.98 598.03 408.33 397.04
Other Current Assets 824.42 1,031.36 1,133.34 658.34 420.92
  1,942.14 2,056.21 2,207.14 1,421.80 1,089.64
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 4,690.04 4,427.13 4,633.12 4,023.69 3,729.37
Current Liabilities          
Borrowings n/a n/a 360.95 22.00 n/a
Other Current Liabilities 932.50 523.24 455.57 416.80 445.46
           
Current Liabilities 932.50 523.24 816.52 438.80 445.46
           
Net Current Assets c1,009.64 c1,532.97 c1,390.63 c982.48 c644.18
           
Borrowings 486.24 830.42 813.52 660.76 662.29
Other Non-Current Liabilities 148.92 105.53 194.42 157.34 220.78
Non-Current Liabilities 635.16 935.95 1,007.94 818.10 883.06
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 1,567.66 1,459.19 1,824.46 1,257.42 1,328.52
           
Net Assets 3,122.38 2,967.94 2,808.66 2,766.27 2,400.85
           
Shareholders Funds 3,122.38 2,967.94 2,808.66 2,766.28 2,400.85
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 3,122.38 2,967.94 2,808.66 2,766.27 2,400.85
Cash Flow 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16 31-Dec-15
Net Cash Flow From Operating Activities 48.26 20.21 (8.76) (227.84) (219.50)
Net Cash Flow from Investing Activities (31.03) 264.35 (305.46) (484.05) (1,179.60)
Net Cash Flow from Financing Activities (73.77) (388.61) 503.91 723.17 920.65
Net Increase/Decrease In Cash (56.54) (104.05) 189.70 11.29 (478.45)
Ratios - based on IFRS 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16 31-Dec-15
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 947.54¢ 829.19¢ 730.46¢ 621.02¢ 494.83¢
Pre-Tax Profit per Share (52.72¢) (79.35¢) (19.95¢) (462.11¢) (86.03¢)
Operating Margin (5.90%) (8.28%) (1.12%) (71.94%) (12.44%)
Return on Capital Employed n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 26.84¢ 11.24¢ (4.87¢) (126.69¢) (122.05¢)
Cash Incr/Decr per Share (31.44¢) (57.86¢) 105.48¢ 6.28¢ (266.04¢)
Net Asset Value per Share (exc. Intangibles) 1,372.75¢ 1,267.29¢ 1,164.43¢ 1,120.69¢ 845.09¢
Net Gearing 1.56% 11.34% 20.52% 9.92% 11.05%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page